Unknown

Dataset Information

0

TFH 2 cells associate with enhanced humoral immunity to SARS-CoV-2 inactivated vaccine in patients with allergic rhinitis.

ABSTRACT:

SUBMITTER: Yao Y 

PROVIDER: S-EPMC8792397 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

T<sub>FH</sub> 2 cells associate with enhanced humoral immunity to SARS-CoV-2 inactivated vaccine in patients with allergic rhinitis.

Yao Yin Y   Wang Zhe-Zheng ZZ   Huang Ao A   Liu Yan Y   Wang Nan N   Wang Zhi-Chao ZC   Yang Lin L   Li Hui-Jun HJ   Xie Jun-Gang JG   Zhu Rong-Fei RF   Cheng Li-Ming LM   Yu Di D   Liu Zheng Z  

Clinical and translational medicine 20220101 1

Similar Datasets

Unknown mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines.
| S-EPMC12823603 | biostudies-literature
Unknown Metabolic control of T<sub>FH</sub> cells and humoral immunity by phosphatidylethanolamine.
| S-EPMC8448202 | biostudies-literature
Unknown MAIT cells activate dendritic cells to promote T<sub>FH</sub> cell differentiation and induce humoral immunity.
| S-EPMC10045373 | biostudies-literature
Unknown The transcription factor Mef2d regulates B:T synapse-dependent GC-T<sub>FH</sub> differentiation and IL-21-mediated humoral immunity.
| S-EPMC10311795 | biostudies-literature
Unknown Impaired Humoral Immunity Identified in Inactivated SARS-CoV-2 Vaccine Recipients without Anti-Spike RBD Antibodies.
| S-EPMC10101072 | biostudies-literature
Unknown Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.
| S-EPMC9580433 | biostudies-literature
Unknown Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.
| S-EPMC12355589 | biostudies-literature
Unknown Der p2‑A20 DNA vaccine attenuates allergic inflammation in mice with allergic rhinitis.
| S-EPMC6854600 | biostudies-literature
Unknown Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development.
| S-EPMC10891849 | biostudies-literature
Unknown A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain.
| S-EPMC9651894 | biostudies-literature